TWD 72.7
(-0.41%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.91 Billion TWD | 6.82% |
2022 | 1.78 Billion TWD | 11.0% |
2021 | 1.61 Billion TWD | -2.27% |
2020 | 1.64 Billion TWD | 1.49% |
2019 | 1.62 Billion TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 526.7 Million TWD | 11.52% |
2024 Q1 | 460.44 Million TWD | -21.01% |
2023 FY | 1.91 Billion TWD | 6.82% |
2023 Q3 | 439.08 Million TWD | 3.9% |
2023 Q4 | 582.89 Million TWD | 32.75% |
2023 Q1 | 467.06 Million TWD | -5.18% |
2023 Q2 | 422.59 Million TWD | -9.52% |
2022 Q4 | 492.59 Million TWD | 0.0% |
2022 FY | 1.78 Billion TWD | 11.0% |
2021 FY | 1.61 Billion TWD | -2.27% |
2020 FY | 1.64 Billion TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Allied Biotech Corporation | 157.72 Million TWD | -1112.003% |
GeneFerm Biotechnology Co., Ltd. | 132.78 Million TWD | -1339.633% |
Easywell Biomedicals, Inc. | 333.45 Million TWD | -473.278% |
Synmosa Biopharma Corporation | 1.49 Billion TWD | -27.477% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 10.972% |
Center Laboratories, Inc. | 697.35 Million TWD | -174.124% |
Tien Liang BioTech Co., Ltd. | 267.27 Million TWD | -615.233% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | -307.887% |
InnoPharmax Inc. | 82.29 Million TWD | -2222.872% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -681.428% |
Excelsior Biopharma Inc. | 388.05 Million TWD | -392.615% |
DV Biomed Co., Ltd. | 575.24 Million TWD | -232.317% |
Foresee Pharmaceuticals Co., Ltd. | 1.12 Billion TWD | -70.438% |
Handa Pharmaceuticals, Inc. | 399.14 Million TWD | -378.927% |
UniPharma Co., Ltd. | 78.32 Million TWD | -2340.764% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | -381.599% |
Alar Pharmaceuticals Inc. | 83.74 Million TWD | -2182.681% |
Winston Medical Supply Co., Ltd. | 151.49 Million TWD | -1161.828% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -322810.642% |
Bioray Biotech Co., Ltd | 96.98 Million TWD | -1871.119% |
TSH Biopharm Corporation Limited | 336.26 Million TWD | -468.483% |